WEDGE CAPITAL MANAGEMENT L L P/NC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1015308 CHARLOTTE, NC

Position in RYTM

as of Mar 31, 2026 · filed Apr 13, 2026 Compact

Position Value

$2,133,808

+$73,610 QoQ

Shares Held

24,535

+27.5% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 79.13185245567557.ToString("F0")% Shared 0.ToString("F0")% None 20.868147544324433.ToString("F0")%

Healthcare · as of Mar 31, 2026

WEDGE CAPITAL MANAGEMENT L L P/NC holds $111,356,380 across 7 Biotechnology names. RYTM ranks #5 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	890,840	$42,733,594
2	REGN	Regeneron Pharmaceuticals, Inc.	39,712	$30,683,079
3	JAZZ	Jazz Pharmaceuticals plc	160,006	$30,249,134
4	HRMY	Harmony Biosciences Holdings, Inc.	88,999	$2,492,861
5	RYTM	Rhythm Pharmaceuticals, Inc. This page	24,535	$2,133,808
6	SVRA	Savara Inc	307,998	$1,681,669
7	TARS	Tarsus Pharmaceuticals, Inc.	19,704	$1,382,235

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,133,808	24,535	+27.5%	Shares	Sole	2026-04-13
2025-12-31	$2,060,198	19,247	-13.5%	Shares	Sole	2026-01-14
2025-09-30	$2,246,421	22,244	-25.8%	Shares	Sole	2025-10-10
2025-06-30	$1,895,131	29,991	-18.9%	Shares	Sole	2025-07-11
2025-03-31	$1,959,042	36,984	-23.6%	Shares	Sole	2025-04-14
2024-12-31	$2,710,047	48,411	-0.9%	Shares	Sole	2025-01-15
2024-09-30	$2,558,937	48,844	-22.7%	Shares	Sole	2024-10-11
2024-06-30	$2,594,868	63,197	-14.5%	Shares	Sole	2024-07-17
2024-03-31	$3,200,917	73,873	-3.4%	Shares	Sole	2024-04-23
2023-12-31	$3,517,026	76,507	-26.9%	Shares	Sole	2024-02-01
2023-09-30	$2,400,706	104,720	-52.1%	Shares	Sole	2023-10-13
2023-06-30	$3,601,828	218,425	—	Shares	Sole	2023-07-17
No filing history on record for this holder in this stock.